LUIS ANTONIO
CASTAÑO GONZÁLEZ
Novo Nordisk
Copenhagen, DinamarcaPublicaciones en colaboración con investigadores/as de Novo Nordisk (4)
2018
-
Targets and teamwork: Understanding differences in pediatric diabetes centers treatment outcomes
Pediatric Diabetes, Vol. 19, Núm. 3, pp. 559-565
2013
-
Lessons from the Hvidoere International Study Group on childhood diabetes: Be dogmatic about outcome and flexible in approach
Pediatric Diabetes, Vol. 14, Núm. 7, pp. 473-480
2010
-
Target setting in intensive insulin management is associated with metabolic control: The Hvidoere Childhood Diabetes Study Group Centre Differences Study 2005
Pediatric Diabetes, Vol. 11, Núm. 4, pp. 271-278
2008
-
Variation within the PPARG gene is associated with residual beta-cell function and glycemic control in children and adolescents during the first year of clinical type 1 diabetes
Pediatric Diabetes, Vol. 9, Núm. 4 PART 1, pp. 297-302